Obesity in patients with COVID-19: a systematic review and meta-analysis
Obesity is common in patients with coronavirus disease 2019 (COVID-19). The effects of obesity on clinical outcomes of COVID-19 warrant systematical investigation. This study explores the effects of obesity with the risk of severe disease among patients with COVID-19. Body mass index (BMI) and degre...
Uloženo v:
| Vydáno v: | Metabolism, clinical and experimental Ročník 113; s. 154378 |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
Elsevier Inc
01.12.2020
|
| Témata: | |
| ISSN: | 0026-0495, 1532-8600, 1532-8600 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Obesity is common in patients with coronavirus disease 2019 (COVID-19). The effects of obesity on clinical outcomes of COVID-19 warrant systematical investigation.
This study explores the effects of obesity with the risk of severe disease among patients with COVID-19.
Body mass index (BMI) and degree of visceral adipose tissue (VAT) accumulation were used as indicators for obesity status. Publication databases including preprints were searched up to August 10, 2020. Clinical outcomes of severe COVID-19 included hospitalization, a requirement for treatment in an intensive care unit (ICU), invasive mechanical ventilation (IMV), and mortality. Risks for severe COVID-19 outcomes are presented as odds ratios (OR) and 95% confidence interval (95%CI) for cohort studies with BMI-defined obesity, and standardized mean difference (SMD) and 95%CI for controlled studies with VAT-defined excessive adiposity.
A total of 45, 650 participants from 30 studies with BMI-defined obesity and 3 controlled studies with VAT-defined adiposity were included for assessing the risk of severe COVID-19. Univariate analyses showed significantly higher ORs of severe COVID-19 with higher BMI: 1.76 (95%: 1.21, 2.56, P = 0.003) for hospitalization, 1.67 (95%CI: 1.26, 2.21, P<0.001) for ICU admission, 2.19 (95%CI: 1.56, 3.07, P<0.001) for IMV requirement, and 1.37 (95%CI: 1.06, 1.75, P = 0.014) for death, giving an overall OR for severe COVID-19 of 1.67 (95%CI: 1.43, 1.96; P<0.001). Multivariate analyses revealed increased ORs of severe COVID-19 associated with higher BMI: 2.36 (95%CI: 1.37, 4.07, P = 0.002) for hospitalization, 2.32 (95%CI: 1.38, 3.90, P = 0.001) for requiring ICU admission, 2.63 (95%CI: 1.32, 5.25, P = 0.006) for IMV support, and 1.49 (95%CI: 1.20, 1.85, P<0.001) for mortality, giving an overall OR for severe COVID-19 of 2.09 (95%CI: 1.67, 2.62; P<0.001). Compared to non-severe COVID-19 patients, severe COVID-19 cases showed significantly higher VAT accumulation with a SMD of 0.49 for hospitalization (95% CI: 0.11, 0.87; P = 0.011), 0.57 (95% CI: 0.33, 0.81; P<0.001) for requiring ICU admission and 0.37 (95% CI: 0.03, 0.71; P = 0.035) for IMV support. The overall SMD for severe COVID-19 was 0.50 (95% CI: 0.33, 0.68; P<0.001).
Obesity increases risk for hospitalization, ICU admission, IMV requirement and death among patients with COVID-19. Further, excessive visceral adiposity appears to be associated with severe COVID-19 outcomes. These findings emphasize the need for effective actions by individuals, the public and governments to increase awareness of the risks resulting from obesity and how these are heightened in the current global pandemic.
•Obesity increases risk for hospitalization among patients with COVID-19.•Obesity increases risk for needing ICU admission among patients with COVID-19.•Obesity increases risk for requiring IMV support among patients with COVID-19.•Obesity increases risk for death among patients with COVID-19.•Excessive visceral adiposity appears to be associated with severe COVID-19 outcomes. |
|---|---|
| AbstractList | •
Obesity increases risk for hospitalization among patients with COVID-19.
•
Obesity increases risk for needing ICU admission among patients with COVID-19.
•
Obesity increases risk for requiring IMV support among patients with COVID-19.
•
Obesity increases risk for death among patients with COVID-19.
•
Excessive visceral adiposity appears to be associated with severe COVID-19 outcomes. Obesity is common in patients with coronavirus disease 2019 (COVID-19). The effects of obesity on clinical outcomes of COVID-19 warrant systematical investigation.BACKGROUNDObesity is common in patients with coronavirus disease 2019 (COVID-19). The effects of obesity on clinical outcomes of COVID-19 warrant systematical investigation.This study explores the effects of obesity with the risk of severe disease among patients with COVID-19.OBJECTIVEThis study explores the effects of obesity with the risk of severe disease among patients with COVID-19.Body mass index (BMI) and degree of visceral adipose tissue (VAT) accumulation were used as indicators for obesity status. Publication databases including preprints were searched up to August 10, 2020. Clinical outcomes of severe COVID-19 included hospitalization, a requirement for treatment in an intensive care unit (ICU), invasive mechanical ventilation (IMV), and mortality. Risks for severe COVID-19 outcomes are presented as odds ratios (OR) and 95% confidence interval (95%CI) for cohort studies with BMI-defined obesity, and standardized mean difference (SMD) and 95%CI for controlled studies with VAT-defined excessive adiposity.METHODSBody mass index (BMI) and degree of visceral adipose tissue (VAT) accumulation were used as indicators for obesity status. Publication databases including preprints were searched up to August 10, 2020. Clinical outcomes of severe COVID-19 included hospitalization, a requirement for treatment in an intensive care unit (ICU), invasive mechanical ventilation (IMV), and mortality. Risks for severe COVID-19 outcomes are presented as odds ratios (OR) and 95% confidence interval (95%CI) for cohort studies with BMI-defined obesity, and standardized mean difference (SMD) and 95%CI for controlled studies with VAT-defined excessive adiposity.A total of 45, 650 participants from 30 studies with BMI-defined obesity and 3 controlled studies with VAT-defined adiposity were included for assessing the risk of severe COVID-19. Univariate analyses showed significantly higher ORs of severe COVID-19 with higher BMI: 1.76 (95%: 1.21, 2.56, P = 0.003) for hospitalization, 1.67 (95%CI: 1.26, 2.21, P<0.001) for ICU admission, 2.19 (95%CI: 1.56, 3.07, P<0.001) for IMV requirement, and 1.37 (95%CI: 1.06, 1.75, P = 0.014) for death, giving an overall OR for severe COVID-19 of 1.67 (95%CI: 1.43, 1.96; P<0.001). Multivariate analyses revealed increased ORs of severe COVID-19 associated with higher BMI: 2.36 (95%CI: 1.37, 4.07, P = 0.002) for hospitalization, 2.32 (95%CI: 1.38, 3.90, P = 0.001) for requiring ICU admission, 2.63 (95%CI: 1.32, 5.25, P = 0.006) for IMV support, and 1.49 (95%CI: 1.20, 1.85, P<0.001) for mortality, giving an overall OR for severe COVID-19 of 2.09 (95%CI: 1.67, 2.62; P<0.001). Compared to non-severe COVID-19 patients, severe COVID-19 cases showed significantly higher VAT accumulation with a SMD of 0.49 for hospitalization (95% CI: 0.11, 0.87; P = 0.011), 0.57 (95% CI: 0.33, 0.81; P<0.001) for requiring ICU admission and 0.37 (95% CI: 0.03, 0.71; P = 0.035) for IMV support. The overall SMD for severe COVID-19 was 0.50 (95% CI: 0.33, 0.68; P<0.001).RESULTSA total of 45, 650 participants from 30 studies with BMI-defined obesity and 3 controlled studies with VAT-defined adiposity were included for assessing the risk of severe COVID-19. Univariate analyses showed significantly higher ORs of severe COVID-19 with higher BMI: 1.76 (95%: 1.21, 2.56, P = 0.003) for hospitalization, 1.67 (95%CI: 1.26, 2.21, P<0.001) for ICU admission, 2.19 (95%CI: 1.56, 3.07, P<0.001) for IMV requirement, and 1.37 (95%CI: 1.06, 1.75, P = 0.014) for death, giving an overall OR for severe COVID-19 of 1.67 (95%CI: 1.43, 1.96; P<0.001). Multivariate analyses revealed increased ORs of severe COVID-19 associated with higher BMI: 2.36 (95%CI: 1.37, 4.07, P = 0.002) for hospitalization, 2.32 (95%CI: 1.38, 3.90, P = 0.001) for requiring ICU admission, 2.63 (95%CI: 1.32, 5.25, P = 0.006) for IMV support, and 1.49 (95%CI: 1.20, 1.85, P<0.001) for mortality, giving an overall OR for severe COVID-19 of 2.09 (95%CI: 1.67, 2.62; P<0.001). Compared to non-severe COVID-19 patients, severe COVID-19 cases showed significantly higher VAT accumulation with a SMD of 0.49 for hospitalization (95% CI: 0.11, 0.87; P = 0.011), 0.57 (95% CI: 0.33, 0.81; P<0.001) for requiring ICU admission and 0.37 (95% CI: 0.03, 0.71; P = 0.035) for IMV support. The overall SMD for severe COVID-19 was 0.50 (95% CI: 0.33, 0.68; P<0.001).Obesity increases risk for hospitalization, ICU admission, IMV requirement and death among patients with COVID-19. Further, excessive visceral adiposity appears to be associated with severe COVID-19 outcomes. These findings emphasize the need for effective actions by individuals, the public and governments to increase awareness of the risks resulting from obesity and how these are heightened in the current global pandemic.CONCLUSIONSObesity increases risk for hospitalization, ICU admission, IMV requirement and death among patients with COVID-19. Further, excessive visceral adiposity appears to be associated with severe COVID-19 outcomes. These findings emphasize the need for effective actions by individuals, the public and governments to increase awareness of the risks resulting from obesity and how these are heightened in the current global pandemic. Obesity is common in patients with coronavirus disease 2019 (COVID-19). The effects of obesity on clinical outcomes of COVID-19 warrant systematical investigation. This study explores the effects of obesity with the risk of severe disease among patients with COVID-19. Body mass index (BMI) and degree of visceral adipose tissue (VAT) accumulation were used as indicators for obesity status. Publication databases including preprints were searched up to August 10, 2020. Clinical outcomes of severe COVID-19 included hospitalization, a requirement for treatment in an intensive care unit (ICU), invasive mechanical ventilation (IMV), and mortality. Risks for severe COVID-19 outcomes are presented as odds ratios (OR) and 95% confidence interval (95%CI) for cohort studies with BMI-defined obesity, and standardized mean difference (SMD) and 95%CI for controlled studies with VAT-defined excessive adiposity. A total of 45, 650 participants from 30 studies with BMI-defined obesity and 3 controlled studies with VAT-defined adiposity were included for assessing the risk of severe COVID-19. Univariate analyses showed significantly higher ORs of severe COVID-19 with higher BMI: 1.76 (95%: 1.21, 2.56, P = 0.003) for hospitalization, 1.67 (95%CI: 1.26, 2.21, P<0.001) for ICU admission, 2.19 (95%CI: 1.56, 3.07, P<0.001) for IMV requirement, and 1.37 (95%CI: 1.06, 1.75, P = 0.014) for death, giving an overall OR for severe COVID-19 of 1.67 (95%CI: 1.43, 1.96; P<0.001). Multivariate analyses revealed increased ORs of severe COVID-19 associated with higher BMI: 2.36 (95%CI: 1.37, 4.07, P = 0.002) for hospitalization, 2.32 (95%CI: 1.38, 3.90, P = 0.001) for requiring ICU admission, 2.63 (95%CI: 1.32, 5.25, P = 0.006) for IMV support, and 1.49 (95%CI: 1.20, 1.85, P<0.001) for mortality, giving an overall OR for severe COVID-19 of 2.09 (95%CI: 1.67, 2.62; P<0.001). Compared to non-severe COVID-19 patients, severe COVID-19 cases showed significantly higher VAT accumulation with a SMD of 0.49 for hospitalization (95% CI: 0.11, 0.87; P = 0.011), 0.57 (95% CI: 0.33, 0.81; P<0.001) for requiring ICU admission and 0.37 (95% CI: 0.03, 0.71; P = 0.035) for IMV support. The overall SMD for severe COVID-19 was 0.50 (95% CI: 0.33, 0.68; P<0.001). Obesity increases risk for hospitalization, ICU admission, IMV requirement and death among patients with COVID-19. Further, excessive visceral adiposity appears to be associated with severe COVID-19 outcomes. These findings emphasize the need for effective actions by individuals, the public and governments to increase awareness of the risks resulting from obesity and how these are heightened in the current global pandemic. Obesity is common in patients with coronavirus disease 2019 (COVID-19). The effects of obesity on clinical outcomes of COVID-19 warrant systematical investigation. This study explores the effects of obesity with the risk of severe disease among patients with COVID-19. Body mass index (BMI) and degree of visceral adipose tissue (VAT) accumulation were used as indicators for obesity status. Publication databases including preprints were searched up to August 10, 2020. Clinical outcomes of severe COVID-19 included hospitalization, a requirement for treatment in an intensive care unit (ICU), invasive mechanical ventilation (IMV), and mortality. Risks for severe COVID-19 outcomes are presented as odds ratios (OR) and 95% confidence interval (95%CI) for cohort studies with BMI-defined obesity, and standardized mean difference (SMD) and 95%CI for controlled studies with VAT-defined excessive adiposity. A total of 45, 650 participants from 30 studies with BMI-defined obesity and 3 controlled studies with VAT-defined adiposity were included for assessing the risk of severe COVID-19. Univariate analyses showed significantly higher ORs of severe COVID-19 with higher BMI: 1.76 (95%: 1.21, 2.56, P = 0.003) for hospitalization, 1.67 (95%CI: 1.26, 2.21, P<0.001) for ICU admission, 2.19 (95%CI: 1.56, 3.07, P<0.001) for IMV requirement, and 1.37 (95%CI: 1.06, 1.75, P = 0.014) for death, giving an overall OR for severe COVID-19 of 1.67 (95%CI: 1.43, 1.96; P<0.001). Multivariate analyses revealed increased ORs of severe COVID-19 associated with higher BMI: 2.36 (95%CI: 1.37, 4.07, P = 0.002) for hospitalization, 2.32 (95%CI: 1.38, 3.90, P = 0.001) for requiring ICU admission, 2.63 (95%CI: 1.32, 5.25, P = 0.006) for IMV support, and 1.49 (95%CI: 1.20, 1.85, P<0.001) for mortality, giving an overall OR for severe COVID-19 of 2.09 (95%CI: 1.67, 2.62; P<0.001). Compared to non-severe COVID-19 patients, severe COVID-19 cases showed significantly higher VAT accumulation with a SMD of 0.49 for hospitalization (95% CI: 0.11, 0.87; P = 0.011), 0.57 (95% CI: 0.33, 0.81; P<0.001) for requiring ICU admission and 0.37 (95% CI: 0.03, 0.71; P = 0.035) for IMV support. The overall SMD for severe COVID-19 was 0.50 (95% CI: 0.33, 0.68; P<0.001). Obesity increases risk for hospitalization, ICU admission, IMV requirement and death among patients with COVID-19. Further, excessive visceral adiposity appears to be associated with severe COVID-19 outcomes. These findings emphasize the need for effective actions by individuals, the public and governments to increase awareness of the risks resulting from obesity and how these are heightened in the current global pandemic. •Obesity increases risk for hospitalization among patients with COVID-19.•Obesity increases risk for needing ICU admission among patients with COVID-19.•Obesity increases risk for requiring IMV support among patients with COVID-19.•Obesity increases risk for death among patients with COVID-19.•Excessive visceral adiposity appears to be associated with severe COVID-19 outcomes. |
| ArticleNumber | 154378 |
| Author | Sui, Yi Lu, Yao Huang, Yan-Mei Ling, Wei Zhao, Hai-Lu Huang, Yi Wang, Min |
| Author_xml | – sequence: 1 givenname: Yi surname: Huang fullname: Huang, Yi organization: Center for Diabetic Systems Medicine, Guangxi Key Laboratory of Excellence, Guilin Medical University, Guilin 541100, China – sequence: 2 givenname: Yao surname: Lu fullname: Lu, Yao organization: Center for Diabetic Systems Medicine, Guangxi Key Laboratory of Excellence, Guilin Medical University, Guilin 541100, China – sequence: 3 givenname: Yan-Mei surname: Huang fullname: Huang, Yan-Mei organization: Department of Geriatrics, Zhongshan Hospital, Fudan University, Shanghai 200032, China – sequence: 4 givenname: Min surname: Wang fullname: Wang, Min organization: Institute of Basic Medical Sciences, Guilin Medical University, Guilin 541100, China – sequence: 5 givenname: Wei surname: Ling fullname: Ling, Wei organization: Center for Diabetic Systems Medicine, Guangxi Key Laboratory of Excellence, Guilin Medical University, Guilin 541100, China – sequence: 6 givenname: Yi surname: Sui fullname: Sui, Yi organization: Department of Clinical Nutrition, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China – sequence: 7 givenname: Hai-Lu surname: Zhao fullname: Zhao, Hai-Lu email: zhaohailu9@126.com organization: Center for Diabetic Systems Medicine, Guangxi Key Laboratory of Excellence, Guilin Medical University, Guilin 541100, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33002478$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNUctu1DAUtVARnRY-AeQlmwx2_BwQIDQ8WqnSbICtZTs31IOTDLGnVf4eRzNU0E1ZWfI9L51zhk76oQeEnlOypITKV9tlB9m6IS5rUpc_wZnSj9CCClZXWhJyghaE1LIifCVO0VlKW0KIUlo-QaeMlRNXeoEuNg5SyBMOPd7ZHKDPCd-GfI3Xm--XHyu6eo0tTlPK0JWzxyPcBLjFtm_wHKCyvY1TCukpetzamODZ8T1H3z5_-rq-qK42Xy7XH64qL2qaK-V4LYW2yrVKcWW5a30jCK2bphZN65Vy2glHqV4RJiUTEmTrOQVuJXG-Yefo3UF3t3cdNL4EHm00uzF0dpzMYIP599KHa_NjuDGq-DNJi8DLo8A4_NpDyqYLyUOMtodhn0zNueZEMzZDX_ztdWfyp74CEAeAH4eURmjvIJSYeSazNceZzDyTOcxUeG_u8XzIpd5hjhzig-z3BzaUnssao0m-DOehCSP4bJohPKjw9p6Cj6EP3safMP0H_zdoDcXR |
| CitedBy_id | crossref_primary_10_3389_fendo_2021_747732 crossref_primary_10_3390_tropicalmed8030147 crossref_primary_10_3390_nu14071388 crossref_primary_10_1111_1756_185X_15407 crossref_primary_10_1016_j_metabol_2024_155812 crossref_primary_10_1093_ofid_ofad311 crossref_primary_10_1016_j_repc_2022_07_004 crossref_primary_10_1016_j_rce_2023_09_001 crossref_primary_10_3390_children8110951 crossref_primary_10_1016_j_orcp_2022_06_003 crossref_primary_10_1016_j_ccrj_2023_10_004 crossref_primary_10_1093_infdis_jiae132 crossref_primary_10_14341_omet12951 crossref_primary_10_3390_antiox12061232 crossref_primary_10_1186_s12879_022_07108_9 crossref_primary_10_1097_SHK_0000000000002063 crossref_primary_10_1016_S0140_6736_22_00484_6 crossref_primary_10_3390_ijerph182111130 crossref_primary_10_1007_s13679_021_00436_y crossref_primary_10_1038_s41598_022_17990_7 crossref_primary_10_1111_cob_12508 crossref_primary_10_1016_j_ejim_2022_11_018 crossref_primary_10_20538_1682_0363_2023_4_164_173 crossref_primary_10_1186_s12879_022_07519_8 crossref_primary_10_1016_j_clnesp_2022_08_014 crossref_primary_10_3390_jcm11226799 crossref_primary_10_1128_spectrum_03005_23 crossref_primary_10_1007_s11010_022_04356_w crossref_primary_10_1080_19490976_2021_1882926 crossref_primary_10_1155_2022_8790810 crossref_primary_10_3390_diagnostics12010010 crossref_primary_10_1002_oby_23292 crossref_primary_10_3390_jpm15060217 crossref_primary_10_3390_cancers14102494 crossref_primary_10_1016_j_jdiacomp_2021_108054 crossref_primary_10_3390_idr16050071 crossref_primary_10_1016_j_jamda_2021_06_010 crossref_primary_10_3389_fpubh_2021_751197 crossref_primary_10_1007_s12325_022_02108_2 crossref_primary_10_4103_jfmpc_jfmpc_1613_24 crossref_primary_10_3389_fimmu_2022_967051 crossref_primary_10_1016_j_rx_2021_09_011 crossref_primary_10_1186_s12879_023_08833_5 crossref_primary_10_1007_s11033_022_07308_1 crossref_primary_10_3389_fimmu_2022_968582 crossref_primary_10_1371_journal_pone_0263146 crossref_primary_10_1016_j_resmer_2022_100904 crossref_primary_10_1007_s12020_021_02671_8 crossref_primary_10_1016_j_rmed_2025_108085 crossref_primary_10_1186_s12966_021_01198_5 crossref_primary_10_1016_j_aforl_2023_11_004 crossref_primary_10_1080_08998280_2024_2358294 crossref_primary_10_2147_DMSO_S441762 crossref_primary_10_1038_s41598_021_85916_w crossref_primary_10_3390_nu14234988 crossref_primary_10_1016_j_rxeng_2021_09_004 crossref_primary_10_1016_S2213_8587_21_00089_9 crossref_primary_10_3390_jcm10245883 crossref_primary_10_1002_jpen_2620 crossref_primary_10_1038_s41598_022_20419_w crossref_primary_10_1002_rmv_2395 crossref_primary_10_3390_jpm12111758 crossref_primary_10_3390_biology12030370 crossref_primary_10_3390_nu13093293 crossref_primary_10_1371_journal_pone_0298215 crossref_primary_10_18332_tid_132411 crossref_primary_10_1097_MAT_0000000000001718 crossref_primary_10_3390_healthcare10091807 crossref_primary_10_3389_fimmu_2022_913732 crossref_primary_10_3390_nu15173806 crossref_primary_10_1111_cob_12514 crossref_primary_10_19127_bshealthscience_1254800 crossref_primary_10_3390_jcm12124054 crossref_primary_10_3390_ijerph18073842 crossref_primary_10_1002_bies_202000211 crossref_primary_10_1186_s13012_021_01114_2 crossref_primary_10_9778_cmajo_20210205 crossref_primary_10_3390_nu14173493 crossref_primary_10_1165_rcmb_2020_0236TR crossref_primary_10_7759_cureus_83711 crossref_primary_10_1016_j_clinthera_2021_02_004 crossref_primary_10_1016_j_bjao_2025_100391 crossref_primary_10_3390_ijms24076729 crossref_primary_10_1016_j_cjca_2021_04_012 crossref_primary_10_1016_j_clnesp_2024_02_023 crossref_primary_10_3390_app11177889 crossref_primary_10_1016_j_clnu_2021_06_020 crossref_primary_10_1113_EP089703 crossref_primary_10_3233_THC_220248 crossref_primary_10_1016_j_clnesp_2024_09_016 crossref_primary_10_1097_MCO_0000000000000740 crossref_primary_10_3389_fimmu_2023_1158455 crossref_primary_10_3390_jcm11133844 crossref_primary_10_5937_jomb0_49377 crossref_primary_10_3389_fimmu_2023_1064101 crossref_primary_10_1016_j_ebiom_2022_103972 crossref_primary_10_3390_jcm14020633 crossref_primary_10_1186_s40337_021_00369_w crossref_primary_10_1093_ckj_sfac083 crossref_primary_10_1136_bmjresp_2021_001070 crossref_primary_10_3390_healthcare10122575 crossref_primary_10_3390_jcm10081545 crossref_primary_10_3389_fmicb_2022_1031231 crossref_primary_10_1002_oby_23096 crossref_primary_10_1007_s40615_022_01268_9 crossref_primary_10_1007_s40520_021_02006_7 crossref_primary_10_52294_8944e106_c54b_40d7_a620_925f7b074f99 crossref_primary_10_1080_14760584_2023_2191716 crossref_primary_10_1016_j_physio_2021_09_001 crossref_primary_10_1016_j_obmed_2024_100538 crossref_primary_10_1002_oby_24069 crossref_primary_10_1002_jmv_28434 crossref_primary_10_1016_j_it_2020_11_002 crossref_primary_10_1016_j_heliyon_2022_e10142 crossref_primary_10_1016_j_clnu_2021_06_019 crossref_primary_10_3389_fendo_2021_748477 crossref_primary_10_3390_life13071572 crossref_primary_10_1016_j_clnesp_2022_07_016 crossref_primary_10_1038_s41598_022_20202_x crossref_primary_10_1038_s41366_021_00938_8 crossref_primary_10_1146_annurev_immunol_101320_030339 crossref_primary_10_1002_iid3_1219 crossref_primary_10_3390_jcm14124075 crossref_primary_10_1177_02601060221127853 crossref_primary_10_1007_s40121_022_00636_6 crossref_primary_10_5492_wjccm_v10_i5_244 crossref_primary_10_1186_s12877_021_02138_5 crossref_primary_10_1002_ijc_34914 crossref_primary_10_22207_JPAM_16_4_50 crossref_primary_10_1016_j_jaip_2021_10_069 crossref_primary_10_3889_oamjms_2022_7922 crossref_primary_10_3390_covid5070097 crossref_primary_10_1136_bmjopen_2021_055003 crossref_primary_10_1097_MCG_0000000000001916 crossref_primary_10_1016_j_jemermed_2021_04_019 crossref_primary_10_1111_cob_12568 crossref_primary_10_1111_jan_16212 crossref_primary_10_3389_fnut_2022_871697 crossref_primary_10_7759_cureus_16704 crossref_primary_10_1186_s12913_022_07797_7 crossref_primary_10_1016_j_clnu_2021_02_020 crossref_primary_10_3390_pathogens11070725 crossref_primary_10_1016_j_dialog_2023_100128 crossref_primary_10_1111_cen_14952 crossref_primary_10_1016_j_vhri_2023_02_004 crossref_primary_10_1111_cts_13297 crossref_primary_10_3389_fmed_2024_1370917 crossref_primary_10_3389_fcvm_2023_1062491 crossref_primary_10_3390_ijerph20021372 crossref_primary_10_1186_s12877_023_04098_4 crossref_primary_10_17116_repro20212703228 crossref_primary_10_1177_22799036221106584 crossref_primary_10_1007_s13105_022_00887_4 crossref_primary_10_1111_jocd_14381 crossref_primary_10_2478_jtim_2022_0020 crossref_primary_10_1161_ATVBAHA_120_315698 crossref_primary_10_1016_j_annepidem_2022_04_003 crossref_primary_10_1186_s40794_025_00258_z crossref_primary_10_3390_diagnostics11061029 crossref_primary_10_1007_s11695_021_05799_8 crossref_primary_10_1016_j_clnu_2022_07_033 crossref_primary_10_1016_j_dsx_2021_01_015 crossref_primary_10_3390_stresses1020010 crossref_primary_10_1038_s41598_021_02370_4 crossref_primary_10_1515_em_2021_0024 crossref_primary_10_7759_cureus_21547 crossref_primary_10_7759_cureus_23726 crossref_primary_10_1038_s41598_022_17197_w crossref_primary_10_1177_15569845231200226 crossref_primary_10_3389_fendo_2021_652765 crossref_primary_10_1136_bmjnph_2021_000375 crossref_primary_10_1186_s12916_021_02058_6 crossref_primary_10_1007_s11102_024_01466_0 crossref_primary_10_1055_s_0042_1757163 crossref_primary_10_1038_s41416_021_01396_9 crossref_primary_10_3389_fendo_2022_936976 crossref_primary_10_3390_v14010025 crossref_primary_10_1016_j_clinsp_2022_100075 crossref_primary_10_7759_cureus_59017 crossref_primary_10_1371_journal_pone_0260381 crossref_primary_10_1265_ehpm_23_00350 crossref_primary_10_1016_j_ajcnut_2023_04_003 crossref_primary_10_3390_nu13051616 crossref_primary_10_3390_ijerph18031030 crossref_primary_10_1016_j_micpath_2025_107839 crossref_primary_10_1016_j_jfutfo_2022_03_012 crossref_primary_10_1371_journal_pone_0274095 crossref_primary_10_3390_jcm11071898 crossref_primary_10_1038_s41366_021_01050_7 crossref_primary_10_3390_tropicalmed6040182 crossref_primary_10_1016_j_obpill_2024_100101 crossref_primary_10_1007_s42000_021_00342_x crossref_primary_10_3389_fnut_2021_617721 crossref_primary_10_1371_journal_pone_0257891 crossref_primary_10_3389_fcimb_2023_1102650 crossref_primary_10_1210_clinem_dgad284 crossref_primary_10_1016_j_ejrad_2021_110031 crossref_primary_10_3389_fmed_2021_770343 crossref_primary_10_1016_j_numecd_2021_07_030 crossref_primary_10_3389_fnut_2023_1218266 crossref_primary_10_1016_j_cgh_2021_09_016 crossref_primary_10_1016_j_clnu_2021_05_006 crossref_primary_10_1016_j_ijid_2022_04_013 crossref_primary_10_3390_healthcare10030480 crossref_primary_10_1007_s11102_021_01148_1 crossref_primary_10_1016_j_freeradbiomed_2021_01_044 crossref_primary_10_3389_fnins_2022_867825 crossref_primary_10_1111_ctr_14376 crossref_primary_10_1016_j_orcp_2021_10_006 crossref_primary_10_1002_jpen_2585 crossref_primary_10_1002_eji_202451226 crossref_primary_10_1259_bjr_20220869 crossref_primary_10_1177_03000605221127520 crossref_primary_10_3389_fendo_2021_726967 crossref_primary_10_1007_s40200_021_00822_2 crossref_primary_10_1111_ene_14912 crossref_primary_10_1186_s12931_022_01977_z crossref_primary_10_7759_cureus_28953 crossref_primary_10_1007_s11695_023_06923_6 crossref_primary_10_1016_j_metabol_2020_154408 crossref_primary_10_1016_S2213_8587_23_00154_7 crossref_primary_10_1249_JSR_0000000000000867 crossref_primary_10_3389_fpsyt_2024_1330278 crossref_primary_10_1007_s00330_023_09426_1 crossref_primary_10_1038_s41598_022_10266_0 crossref_primary_10_1016_j_asmr_2022_03_007 crossref_primary_10_1016_j_metabol_2021_154820 crossref_primary_10_1136_bmjopen_2021_051230 crossref_primary_10_1111_dom_14382 crossref_primary_10_1016_j_diabres_2021_109031 crossref_primary_10_1016_j_metabol_2022_155333 crossref_primary_10_1007_s00423_024_03283_2 crossref_primary_10_1007_s11357_023_01058_z crossref_primary_10_1111_ijn_13147 crossref_primary_10_1016_j_metabol_2022_155217 crossref_primary_10_1016_S2213_8587_22_00158_9 crossref_primary_10_3390_vaccines11040716 crossref_primary_10_7759_cureus_42205 crossref_primary_10_1186_s12889_025_24057_5 crossref_primary_10_1371_journal_pone_0256988 crossref_primary_10_3389_fpubh_2022_748498 crossref_primary_10_1007_s11154_021_09672_y crossref_primary_10_1038_s41366_021_00907_1 crossref_primary_10_1186_s12933_021_01254_1 crossref_primary_10_1016_j_eprac_2021_12_009 crossref_primary_10_1016_j_jiac_2024_04_007 crossref_primary_10_14423_SMJ_0000000000001754 crossref_primary_10_1016_j_jjcc_2022_08_011 crossref_primary_10_1007_s10815_022_02622_w crossref_primary_10_1007_s13679_024_00562_3 crossref_primary_10_3390_jcm11030622 crossref_primary_10_1016_j_clnu_2021_10_020 crossref_primary_10_1097_CCE_0000000000000737 crossref_primary_10_1111_ajt_16746 crossref_primary_10_3390_ijms25147899 crossref_primary_10_5114_pjr_2023_125407 crossref_primary_10_1371_journal_pone_0280291 crossref_primary_10_7759_cureus_72097 crossref_primary_10_3390_vaccines10081167 crossref_primary_10_1111_dom_14523 crossref_primary_10_1017_S0007114521000921 crossref_primary_10_3390_diseases11040165 crossref_primary_10_2478_prolas_2021_0061 crossref_primary_10_3889_oamjms_2021_6585 crossref_primary_10_3892_etm_2022_11315 crossref_primary_10_1002_hsr2_765 crossref_primary_10_3390_jcm11195758 crossref_primary_10_3390_antibiotics12030587 crossref_primary_10_1136_bmjnph_2021_000391 crossref_primary_10_1186_s12931_022_02265_6 crossref_primary_10_1002_oby_23121 crossref_primary_10_1111_obr_13803 crossref_primary_10_1016_j_clnesp_2022_04_005 crossref_primary_10_1097_MD_0000000000038266 crossref_primary_10_1016_j_obmed_2022_100420 crossref_primary_10_1002_osp4_692 crossref_primary_10_1016_j_heliyon_2023_e15824 crossref_primary_10_1016_j_jiac_2023_08_004 crossref_primary_10_3390_biomedicines10082007 crossref_primary_10_1016_j_rceng_2023_10_002 crossref_primary_10_1183_16000617_0098_2022 crossref_primary_10_3390_electronics13061005 crossref_primary_10_1136_bmjopen_2021_051711 crossref_primary_10_1016_j_anorl_2024_02_008 crossref_primary_10_1056_NEJMoa2114583 crossref_primary_10_3389_fendo_2021_598249 crossref_primary_10_1002_JLB_4COVA0121_084RR crossref_primary_10_3390_su142214785 crossref_primary_10_1371_journal_pone_0288106 crossref_primary_10_3390_biom14070835 crossref_primary_10_1111_obr_13496 crossref_primary_10_3390_jcm10061218 crossref_primary_10_1007_s13679_021_00466_6 |
| Cites_doi | 10.1093/infdis/jiy370 10.1136/bmj.k4817 10.1002/oby.22941 10.1038/s41366-020-0597-4 10.1038/sj.ijo.0803683 10.1016/j.diabres.2020.108331 10.2337/dc16-1025 10.1016/j.metabol.2020.154249 10.1016/j.metabol.2020.154319 10.1056/NEJMc2010419 10.1016/j.dsx.2020.05.020 10.1016/S1470-2045(20)30096-6 10.1016/S1473-3099(20)30371-6 10.1093/cid/ciaa415 10.1016/j.dsx.2020.06.060 10.1016/j.metabol.2020.154256 10.1093/cid/ciaa1012 10.1111/j.1440-1843.2011.02096.x 10.1016/S2213-8587(19)30084-1 10.1111/obr.13034 10.1161/CIRCULATIONAHA.114.015000 10.1016/S0140-6736(20)31189-2 10.1371/journal.pmed.1001053 10.1136/bmj.m1966 10.1002/oby.22859 10.1177/0194599820929640 10.1530/EJE-20-0541 10.1111/j.1467-789X.2011.00864.x 10.1016/j.ijid.2020.07.029 10.1007/s00592-020-01522-8 10.1016/j.phrs.2020.104931 10.1152/ajpendo.00198.2020 10.1002/oby.22831 10.1073/pnas.1716561115 10.1016/S0140-6736(20)31024-2 10.1016/j.orcp.2020.07.002 10.1038/s41574-020-0364-6 10.2337/dc20-0576 10.3389/fcimb.2018.00343 10.1002/dmrr.3325 10.2337/dc20-1333 10.1016/j.jpeds.2020.05.006 10.1056/NEJMc2007617 10.1073/pnas.1809046116 10.1053/meta.2001.21693 10.1016/j.metabol.2020.154251 10.1016/j.metabol.2020.154317 10.1161/CIRCULATIONAHA.120.047659 10.5811/westjem.2020.5.47972 |
| ContentType | Journal Article |
| Copyright | 2020 Elsevier Inc. Copyright © 2020 Elsevier Inc. All rights reserved. 2020 Elsevier Inc. All rights reserved. 2020 Elsevier Inc. |
| Copyright_xml | – notice: 2020 Elsevier Inc. – notice: Copyright © 2020 Elsevier Inc. All rights reserved. – notice: 2020 Elsevier Inc. All rights reserved. 2020 Elsevier Inc. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.1016/j.metabol.2020.154378 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1532-8600 |
| EndPage | 154378 |
| ExternalDocumentID | PMC7521361 33002478 10_1016_j_metabol_2020_154378 S0026049520302420 |
| Genre | Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review Journal Article |
| GroupedDBID | --- --K --M -~X .1- .55 .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYJJ AAYWO ABBQC ABDPE ABFNM ABGSF ABJNI ABMAC ABMZM ABUDA ABWVN ABXDB ACDAQ ACIEU ACLOT ACRLP ACRPL ADBBV ADEZE ADMUD ADNMO ADUVX AEBSH AEHWI AEIPS AEKER AEVXI AFFNX AFJKZ AFRHN AFTJW AFXIZ AGHFR AGQPQ AGRDE AGUBO AGYEJ AHHHB AIEXJ AIIUN AIKHN AITUG AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDZ HMK HMO HVGLF HX~ HZ~ IHE J1W J5H K-O KOM L7B LZ1 M29 M41 MO0 MVM N9A O-L O9- OAUVE OB0 OHT ON- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSU SSZ T5K UAP UHS WUQ X7M Z5R ZGI ~G- ~HD ~KM AACTN AAIAV ABLVK ABYKQ AFCTW AFKWA AHPSJ AJBFU AJOXV AMFUW DOVZS G8K LCYCR RIG ZA5 9DU AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c521t-7b42658a7bf7747a4bfcd5012dd25dfc77b8b5b11890366356e6fc41e4a60bcd3 |
| ISICitedReferencesCount | 317 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000593872400007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0026-0495 1532-8600 |
| IngestDate | Tue Sep 30 15:59:30 EDT 2025 Wed Oct 01 13:54:35 EDT 2025 Thu Apr 03 07:08:33 EDT 2025 Tue Nov 18 22:34:12 EST 2025 Sat Nov 29 07:26:01 EST 2025 Fri Feb 23 02:46:07 EST 2024 Tue Oct 14 19:30:03 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Obesity Intensive care OR Coronavirus disease 2019 Mortality SAT VAT MeSH Visceral adipose tissue SMD COVID-19 CT ACE2 SARS-CoV-2 IMV NOS Invasive mechanical ventilation 95%CI CNKI ICU DKD BMI IAV |
| Language | English |
| License | Copyright © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c521t-7b42658a7bf7747a4bfcd5012dd25dfc77b8b5b11890366356e6fc41e4a60bcd3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 Yi Huang and Yao Lu contributed equally to this work. |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7521361 |
| PMID | 33002478 |
| PQID | 2448408331 |
| PQPubID | 23479 |
| PageCount | 1 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7521361 proquest_miscellaneous_2448408331 pubmed_primary_33002478 crossref_primary_10_1016_j_metabol_2020_154378 crossref_citationtrail_10_1016_j_metabol_2020_154378 elsevier_sciencedirect_doi_10_1016_j_metabol_2020_154378 elsevier_clinicalkey_doi_10_1016_j_metabol_2020_154378 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-12-01 |
| PublicationDateYYYYMMDD | 2020-12-01 |
| PublicationDate_xml | – month: 12 year: 2020 text: 2020-12-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Metabolism, clinical and experimental |
| PublicationTitleAlternate | Metabolism |
| PublicationYear | 2020 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Short, Kedzierska, van de Sandt (bb0210) 2018; 8 Muscogiuri, Pugliese, Barrea, Savastano, Colao (bb0250) 2020; 108 Steinberg, Wright, Kushner (bb0405) 2020; 21 Borobia, Carcas, Arnalich, Alvarez-Sala, Montserrat, Quintana (bb0085) 2020 Giacomelli, Ridolfo, Milazzo, Oreni, Bernacchia, Siano (bb0055) 2020; 158 Chandarana, Dane, Mikheev, Taffel, Feng, Rusinek (bb0130) 2020 Hussain, Vasas, El-Hasani (bb0260) 2020; 108 Pranata, Lim, Yonas, Vania, Lukito, Siswanto (bb0155) 2020; S1262-3636 Soeroto, Soetedjo, Purwiga, Santoso, Kulsum, Suryadinata (bb0170) 2020 World Health Organization (bb0010) 2020 Sales-Peres, de Azevedo-Silva, Bonato, Sales-Peres, Pinto, Santiago Junior (bb0145) 2020 Kass, Duggal, Cingolani (bb0195) 2020; 395 Hur, Price, Gray, Gulati, Maksimoski, Racette (bb0370) 2020; 163 Watanabe, Caruso, Tuccinardi, Risi, Zerunian, Polici (bb0070) 2020 Mejia-Vilet, Cordova-Sanchez, Fernandez-Camargo, Mendez-Perez, Morales-Buenrostro, Hernandez-Gilsoul (bb0365) 2020 Pettit NN, MacKenzie EL, Ridgway J, Pursell K, Ash D, Patel B, et al. Obesity is associated with increased risk for mortality among hospitalized patients with COVID-19 [published online ahead of print, 2020 Jun 26]. Obesity (Silver Spring) 2020. Foldi, Farkas, Kiss, Zadori, Vancsa, Szako (bb0150) 2020 Tamara, Tahapary (bb0135) 2020; 14 Chiappetta, Sharma, Bottino, Stier (bb0290) 2020; 44 Chao, Derespina, Herold, Goldman, Aldrich, Weingarten (bb0105) 2020; 223 Sattar, McInnes, McMurray (bb0285) 2020; 142 Hu, Yang, Zhang, Yang, Cao, Li (bb0305) 2016; 39 Simonnet, Chetboun, Poissy, Raverdy, Noulette, Duhamel (bb0040) 2020; 28 Van Kerkhove, Vandemaele, Shinde, Jaramillo-Gutierrez, Koukounari, Donnelly (bb0225) 2011; 8 Regina, Papadimitriou-Olivgeris, Burger, Filippidis, Tschopp, Desgranges (bb0380) 2020 de Lusignan, Dorward, Correa, Jones, Akinyemi, Amirthalingam (bb0030) 2020 Ebinger, Achamallah, Ji, Claggett, Sun, Botting (bb0095) 2020 Littleton (bb0235) 2012; 17 Yan, Grantham, Pantelic (bb0275) 2018; 115 Robilotti, Babady, Mead, Rolling, Perez-Johnston, Bernardes (bb0375) 2020 Shekhar, Upadhyay, Sheikh, Atencio, Kapuria (bb0100) 2020 Ohkawara, Tanaka, Miyachi, Ishikawa-Takata, Tabata (bb0330) 2007; 31 . Parri, Lenge, Buonsenso (bb0190) 2020; 383 Hussain A, Mahawar K, Xia Z, Yang W, El-Hasani S. Obesity and mortality of COVID-19. Meta-analysis [published online ahead of print, 2020 Jul 9]. Obes Res Clin Pract 2020; 14(4): 295–300. Kassir (bb0265) 2020; 21 Petrilli, Jones, Yang, Rajagopalan, O’Donnell, Chernyak (bb0360) 2020; 369 World Health Organization (bb0185) 2017 Maier, Lopez, Sanchez, Ng, Gresh, Ojeda (bb0270) 2018; 218 Goyal, Choi, Pinheiro, Schenck, Chen, Jabri (bb0345) 2020; 382 Petersen, Bressem, Albrecht, Thiess, Vahldiek, Hamm (bb0325) 2020; 110 Neeland, Ross, Despres, Matsuzawa, Yamashita, Shai (bb0320) 2019; 7 Cai, Chen, Wang, Luo, Liu, Wu (bb0045) 2020; 43 Gaibazzi, Martini, Mattioli, Tuttolomondo, Guidorossi, Suma (bb0110) 2020 Kim L, Garg S, O'Halloran A, Whitaker M, Pham H, Anderson EJ, et al. Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET). Preprint at medRxiv 2020. Palaiodimos, Kokkinidis, Li, Karamanis, Ognibene, Arora (bb0060) 2020; 108 Kalligeros, Shehadeh, Mylona, Benitez, Beckwith, Chan (bb0340) 2020; 28 Yang, Hu, Zhu (bb0165) 2020 Argenziano, Bruce, Slater, Tiao, Baldwin, Barr (bb0350) 2020 Sattar, Ho, Gill, Ghouri, Gray, Celis-Morales (bb0205) 2020; 14 Murillo-Zamora, Hernandez-Suarez (bb0390) 2020 World Health Organization (bb0025) 2020 West-Eberhard (bb0300) 2019; 116 Abraham, Pedley, Massaro, Hoffmann, Fox (bb0315) 2015; 132 Carrillo-Vega, Salinas-Escudero, Garcia-Peña, Gutierrez-Robledo, Parra-Rodriguez (bb0120) 2020 Rottoli, Bernante, Belvedere, Balsamo, Garelli, Giannella (bb0400) 2020; 183 Fezeu, Julia, Henegar, Bitu, Hu, Grobbee (bb0220) 2011; 12 Zhou, Yang, Chi, Dong, Lv, Shen (bb0255) 2020; 99 Huang, Wang, Zheng, Liu, Chen, George (bb0245) 2020; 108 World Health Organization (bb0005) 2020 Zhu, Hasegawa, Ma, Fujiogi, Camargo, Liang (bb0335) 2020; 154345 Al-Sabah, Al-Haddad, Al Youha, Jamal, AlMazeedi (bb0355) 2020 Nakeshbandi, Maini, Daniel, Rosengarten, Parmar, Wilson (bb0410) 2020 Liang, Guan, Chen, Wang, Li, Xu (bb0020) 2020; 21 Yang, Ding, Zou, Shen, Hu, Hu (bb0075) 2020 Halvatsiotis, Kotanidou, Tzannis, Jahaj, Magira, Theodorakopoulou (bb0395) 2020; 166 Murad, Wang, Chu, Lin (bb0080) 2019; 364 Battisti S, Pedone C, Napoli N, Russo E, Agnoletti V, Nigra SG, et al. Computed tomography highlights increased visceral adiposity associated with critical illness in COVID-19 [published online ahead of print, 2020 Aug 4]. Diabetes Care 2020: dc201333. Luzi, Radaelli (bb0215) 2020; 57 Petrilli, Jones, Yang, Rajagopalan, O’Donnell, Chernyak (bb0035) 2020 Shi, Wang, Wang, Duan, Yang (bb0240) 2020; S0163-4453 Smith, Lovejoy, Greenway, Ryan (bb0310) 2001; 50 Lighter, Phillips, Hochman, Sterling, Johnson, Francois (bb0050) 2020; 71 Cummings, Baldwin, Abrams, Jacobson, Meyer, Balough (bb0065) 2020; 395 Antwi-Amoabeng, Beutler, Awad, Kanji, Mahboob, Ghuman (bb0385) 2020 Malik, Ravindra, Attri, Bhadada, Singh (bb0140) 2020 Berlin, Gulick, Martinez (bb0015) 2020 Giorgi Rossi, Marino, Formisano, Venturelli, Vicentini, Grilli (bb0115) 2020 Klang, Kassim, Soffer, Freeman, Levin, Reich (bb0200) 2020 Watanabe, Risi, Tuccinardi, Baquero, Manfrini, Gnessi (bb0295) 2020 Stefan, Birkenfeld, Schulze, Ludwig (bb0230) 2020; 16 Korakas, Ikonomidis, Kousathana, Balampanis, Kountouri, Raptis (bb0280) 2020; 319 Prevention CfDCa (bb0180) 2020 Smith (10.1016/j.metabol.2020.154378_bb0310) 2001; 50 Watanabe (10.1016/j.metabol.2020.154378_bb0295) 2020 Sattar (10.1016/j.metabol.2020.154378_bb0205) 2020; 14 Petrilli (10.1016/j.metabol.2020.154378_bb0360) 2020; 369 Muscogiuri (10.1016/j.metabol.2020.154378_bb0250) 2020; 108 Argenziano (10.1016/j.metabol.2020.154378_bb0350) 2020 Shi (10.1016/j.metabol.2020.154378_bb0240) 2020; S0163-4453 World Health Organization (10.1016/j.metabol.2020.154378_bb0010) Carrillo-Vega (10.1016/j.metabol.2020.154378_bb0120) 2020 Prevention CfDCa (10.1016/j.metabol.2020.154378_bb0180) Sattar (10.1016/j.metabol.2020.154378_bb0285) 2020; 142 Ebinger (10.1016/j.metabol.2020.154378_bb0095) 2020 Cummings (10.1016/j.metabol.2020.154378_bb0065) 2020; 395 Hussain (10.1016/j.metabol.2020.154378_bb0260) 2020; 108 Neeland (10.1016/j.metabol.2020.154378_bb0320) 2019; 7 Kalligeros (10.1016/j.metabol.2020.154378_bb0340) 2020; 28 Zhu (10.1016/j.metabol.2020.154378_bb0335) 2020; 154345 Van Kerkhove (10.1016/j.metabol.2020.154378_bb0225) 2011; 8 Lighter (10.1016/j.metabol.2020.154378_bb0050) 2020; 71 Foldi (10.1016/j.metabol.2020.154378_bb0150) 2020 Littleton (10.1016/j.metabol.2020.154378_bb0235) 2012; 17 Petersen (10.1016/j.metabol.2020.154378_bb0325) 2020; 110 Kass (10.1016/j.metabol.2020.154378_bb0195) 2020; 395 Steinberg (10.1016/j.metabol.2020.154378_bb0405) 2020; 21 Palaiodimos (10.1016/j.metabol.2020.154378_bb0060) 2020; 108 World Health Organization (10.1016/j.metabol.2020.154378_bb0005) Sales-Peres (10.1016/j.metabol.2020.154378_bb0145) 2020 Fezeu (10.1016/j.metabol.2020.154378_bb0220) 2011; 12 Short (10.1016/j.metabol.2020.154378_bb0210) 2018; 8 Antwi-Amoabeng (10.1016/j.metabol.2020.154378_bb0385) 2020 Borobia (10.1016/j.metabol.2020.154378_bb0085) 2020 Simonnet (10.1016/j.metabol.2020.154378_bb0040) 2020; 28 World Health Organization (10.1016/j.metabol.2020.154378_bb0025) Abraham (10.1016/j.metabol.2020.154378_bb0315) 2015; 132 Mejia-Vilet (10.1016/j.metabol.2020.154378_bb0365) 2020 Nakeshbandi (10.1016/j.metabol.2020.154378_bb0410) 2020 Chao (10.1016/j.metabol.2020.154378_bb0105) 2020; 223 Petrilli (10.1016/j.metabol.2020.154378_bb0035) 2020 Maier (10.1016/j.metabol.2020.154378_bb0270) 2018; 218 Soeroto (10.1016/j.metabol.2020.154378_bb0170) 2020 Al-Sabah (10.1016/j.metabol.2020.154378_bb0355) 2020 Yan (10.1016/j.metabol.2020.154378_bb0275) 2018; 115 Berlin (10.1016/j.metabol.2020.154378_bb0015) 2020 Watanabe (10.1016/j.metabol.2020.154378_bb0070) 2020 Giacomelli (10.1016/j.metabol.2020.154378_bb0055) 2020; 158 Malik (10.1016/j.metabol.2020.154378_bb0140) 2020 Stefan (10.1016/j.metabol.2020.154378_bb0230) 2020; 16 Halvatsiotis (10.1016/j.metabol.2020.154378_bb0395) 2020; 166 World Health Organization (10.1016/j.metabol.2020.154378_bb0185) Shekhar (10.1016/j.metabol.2020.154378_bb0100) 2020 Klang (10.1016/j.metabol.2020.154378_bb0200) 2020 10.1016/j.metabol.2020.154378_bb0125 Zhou (10.1016/j.metabol.2020.154378_bb0255) 2020; 99 Robilotti (10.1016/j.metabol.2020.154378_bb0375) 2020 Tamara (10.1016/j.metabol.2020.154378_bb0135) 2020; 14 10.1016/j.metabol.2020.154378_bb0175 Ohkawara (10.1016/j.metabol.2020.154378_bb0330) 2007; 31 10.1016/j.metabol.2020.154378_bb0090 Hu (10.1016/j.metabol.2020.154378_bb0305) 2016; 39 Luzi (10.1016/j.metabol.2020.154378_bb0215) 2020; 57 Liang (10.1016/j.metabol.2020.154378_bb0020) 2020; 21 Chiappetta (10.1016/j.metabol.2020.154378_bb0290) 2020; 44 Giorgi Rossi (10.1016/j.metabol.2020.154378_bb0115) 2020 Goyal (10.1016/j.metabol.2020.154378_bb0345) 2020; 382 Parri (10.1016/j.metabol.2020.154378_bb0190) 2020; 383 de Lusignan (10.1016/j.metabol.2020.154378_bb0030) 2020 Cai (10.1016/j.metabol.2020.154378_bb0045) 2020; 43 West-Eberhard (10.1016/j.metabol.2020.154378_bb0300) 2019; 116 Regina (10.1016/j.metabol.2020.154378_bb0380) 2020 Murad (10.1016/j.metabol.2020.154378_bb0080) 2019; 364 Korakas (10.1016/j.metabol.2020.154378_bb0280) 2020; 319 Chandarana (10.1016/j.metabol.2020.154378_bb0130) 2020 Yang (10.1016/j.metabol.2020.154378_bb0075) 2020 Huang (10.1016/j.metabol.2020.154378_bb0245) 2020; 108 Murillo-Zamora (10.1016/j.metabol.2020.154378_bb0390) 2020 10.1016/j.metabol.2020.154378_bb0160 Kassir (10.1016/j.metabol.2020.154378_bb0265) 2020; 21 Pranata (10.1016/j.metabol.2020.154378_bb0155) 2020; S1262-3636 Yang (10.1016/j.metabol.2020.154378_bb0165) 2020 Rottoli (10.1016/j.metabol.2020.154378_bb0400) 2020; 183 Gaibazzi (10.1016/j.metabol.2020.154378_bb0110) 2020 Hur (10.1016/j.metabol.2020.154378_bb0370) 2020; 163 |
| References_xml | – volume: 50 start-page: 425 year: 2001 end-page: 435 ident: bb0310 article-title: deJonge L, de la Bretonne J, et al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity publication-title: Metabolism – year: 2020 ident: bb0150 article-title: Obesity is a risk factor for developing critical condition in COVID-19 patients: a systematic review and meta-analysis [published online ahead of print, 2020 Jul 19] publication-title: Obes Rev – year: 2020 ident: bb0075 article-title: Visceral Adiposity and High Intramuscular Fat Deposition Independently Predict Critical Illness in Patients with Sars-COV-2 [published online ahead of print, 2020 Jul 17] publication-title: Obesity (Silver Spring) – year: 2020 ident: bb0390 article-title: Survival in adult inpatients with COVID-19 publication-title: Preprint at medRxiv – volume: 7 start-page: 715 year: 2019 end-page: 725 ident: bb0320 article-title: Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement publication-title: Lancet Diabetes Endocrinol – year: 2020 ident: bb0385 article-title: Sociodemographic predictors of outcomes in COVID-19: examining the impact of ethnic disparities in Northern Nevada publication-title: Preprint at medRxiv – year: 2020 ident: bb0120 article-title: Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico publication-title: Preprint at medRxiv – start-page: 1 year: 2020 end-page: 9 ident: bb0140 article-title: Higher body mass index is an important risk factor in COVID-19 patients: a systematic review and meta-analysis [published online ahead of print, 2020 Jul 24] publication-title: Environ Sci Pollut Res Int – volume: 108 start-page: 154262 year: 2020 ident: bb0060 article-title: Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx publication-title: New York Metabolism – year: 2020 ident: bb0145 article-title: Coronavirus (SARS-CoV-2) and the risk of obesity for critically illness and ICU admitted: meta-analysis of the pidemiological evidence [published online ahead of print, 2020 Aug 3] publication-title: Obes Res Clin Pract – volume: 383 start-page: 187 year: 2020 end-page: 190 ident: bb0190 article-title: Coronavirus infection in pediatric emergency departments research G. children with Covid-19 in pediatric emergency departments in Italy publication-title: N Engl J Med – year: 2020 ident: bb0355 article-title: COVID-19: impact of obesity and diabetes in disease severity publication-title: Preprint at medRxiv – year: 2020 ident: bb0165 article-title: Obesity aggravates COVID-19: a systematic review and meta-analysis [published online ahead of print, 2020 Jun 30] publication-title: J Med Virol – start-page: e3325 year: 2020 ident: bb0295 article-title: Obesity and SARS-CoV-2: a population to safeguard publication-title: Diabetes Metab Res Rev – volume: 28 start-page: 1200 year: 2020 end-page: 1204 ident: bb0340 article-title: Association of obesity with disease severity among patients with COVID-19 publication-title: Obesity – year: 2020 ident: bb0180 article-title: Adult obesity facts | overweight & obesity – volume: 223 start-page: 14 year: 2020 end-page: 19 ident: bb0105 article-title: Clinical characteristics and outcomes of hospitalized and critically ill children and adolescents with coronavirus disease 2019 (COVID-19) at a tertiary care medical center in New York City publication-title: J Pediatr – volume: 158 start-page: 104931 year: 2020 ident: bb0055 article-title: 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study publication-title: Pharmacol Res – year: 2020 ident: bb0350 article-title: Characterization and clinical course of 1000 Patients with COVID-19 in New York: retrospective case series publication-title: Preprint at medRxiv – volume: 154345 year: 2020 ident: bb0335 article-title: Obesity & genetic predisposition with COVID-19 publication-title: Metabolism – volume: 28 start-page: 1195 year: 2020 end-page: 1199 ident: bb0040 article-title: High prevalence of obesity in severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation publication-title: Obesity (Silver Spring) – volume: 395 start-page: 1763 year: 2020 end-page: 1770 ident: bb0065 article-title: Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study publication-title: Lancet – year: 2017 ident: bb0185 article-title: Prevalence of obesity among adults, BMI ≥ 30, age-standardized - estimates by country – volume: 57 start-page: 759 year: 2020 end-page: 764 ident: bb0215 article-title: Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic publication-title: Acta Diabetol – volume: 31 start-page: 1786 year: 2007 end-page: 1797 ident: bb0330 article-title: A dose-response relation between aerobic exercise and visceral fat reduction: systematic review of clinical trials publication-title: Int J Obes (Lond) – volume: 8 start-page: 343 year: 2018 ident: bb0210 article-title: Back to the future: lessons learned from the 1918 influenza pandemic publication-title: Front Cell Infect Microbiol – year: 2020 ident: bb0115 article-title: Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio Emilia, Italy publication-title: Preprint at medRxiv – volume: S0163-4453 start-page: 30288 year: 2020 ident: bb0240 article-title: Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19 [published online ahead of print, 2020 May 15] publication-title: J Infect – year: 2020 ident: bb0095 article-title: Pre-existing traits associated with Covid-19 illness severity publication-title: Preprint at medRxiv – reference: Hussain A, Mahawar K, Xia Z, Yang W, El-Hasani S. Obesity and mortality of COVID-19. Meta-analysis [published online ahead of print, 2020 Jul 9]. Obes Res Clin Pract 2020; 14(4): 295–300. – volume: 21 start-page: 752 year: 2020 end-page: 755 ident: bb0405 article-title: In young adults with COVID-19, obesity is associated with adverse outcomeS publication-title: West J Emerg Med – volume: 382 start-page: 2372 year: 2020 end-page: 2374 ident: bb0345 article-title: Clinical characteristics of Covid-19 in New York City publication-title: N Engl J Med – volume: 17 start-page: 43 year: 2012 end-page: 49 ident: bb0235 article-title: Impact of obesity on respiratory function publication-title: Respirology – volume: 183 start-page: 389 year: 2020 end-page: 397 ident: bb0400 article-title: How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre publication-title: Eur J Endocrinol – start-page: 1 year: 2020 end-page: 6 ident: bb0410 article-title: The impact of obesity on COVID-19 complications: a retrospective cohort study publication-title: Int J Obes (Lond) – volume: 110 start-page: 154317 year: 2020 ident: bb0325 article-title: The role of visceral adiposity in the severity of COVID-19: highlights from a unicenter cross-sectional pilot study in Germany publication-title: Metabolism – volume: 44 start-page: 1790 year: 2020 end-page: 1792 ident: bb0290 article-title: COVID-19 and the role of chronic inflammation in patients with obesity publication-title: Int J Obes (Lond) – year: 2020 ident: bb0035 article-title: Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City publication-title: Preprint at medRxiv – volume: 142 start-page: 4 year: 2020 end-page: 6 ident: bb0285 article-title: Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms publication-title: Circulation – year: 2020 ident: bb0365 article-title: Derivation of a score to predict admission to intensive care unit in patients with COVID-19: the ABC-GOALS score publication-title: Preprint at medRxiv – volume: 395 start-page: 1544 year: 2020 end-page: 1545 ident: bb0195 article-title: Obesity could shift severe COVID-19 disease to younger ages publication-title: The Lancet – year: 2020 ident: bb0005 article-title: Coronavirus – volume: 163 start-page: 170 year: 2020 end-page: 178 ident: bb0370 article-title: Factors associated with intubation and prolonged intubation in hospitalized patients with COVID-19 publication-title: Otolaryngol Head Neck Surg – reference: Pettit NN, MacKenzie EL, Ridgway J, Pursell K, Ash D, Patel B, et al. Obesity is associated with increased risk for mortality among hospitalized patients with COVID-19 [published online ahead of print, 2020 Jun 26]. Obesity (Silver Spring) 2020. – year: 2020 ident: bb0200 article-title: Severe obesity as an independent risk factor for COVID-19 mortality in hospitalized patients younger than 50 [published online ahead of print, 2020 May 23] publication-title: Obesity (Silver Spring) – year: 2020 ident: bb0030 article-title: Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of general practitioners research and surveillance Centre primary care network: a cross-sectional study[published online ahead of print, 2020 May 15] publication-title: Lancet Infect Dis – year: 2020 ident: bb0015 article-title: Severe Covid-19[published online ahead of print, 2020 May 15] publication-title: N Engl J Med – volume: 39 start-page: e179 year: 2016 end-page: e180 ident: bb0305 article-title: Abdominal obesity is more closely associated with diabetic kidney disease than general obesity publication-title: Diabetes Care – year: 2020 ident: bb0085 article-title: A cohort of patients with COVID-19 in a major teaching hospital in Europe publication-title: Preprint at medRxiv – volume: S1262-3636 start-page: 30097 year: 2020 ident: bb0155 article-title: Body mass index and outcome in patients with COVID-19: a dose-response meta-analysis [published online ahead of print, 2020 Jul 29] publication-title: Diabetes Metab – volume: 115 start-page: 1081 year: 2018 end-page: 1086 ident: bb0275 article-title: Bueno de Mesquita PJ, Albert B, Liu F, et al. Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community publication-title: Proc Natl Acad Sci U S A – reference: Battisti S, Pedone C, Napoli N, Russo E, Agnoletti V, Nigra SG, et al. Computed tomography highlights increased visceral adiposity associated with critical illness in COVID-19 [published online ahead of print, 2020 Aug 4]. Diabetes Care 2020: dc201333. – volume: 21 start-page: 335 year: 2020 end-page: 337 ident: bb0020 article-title: Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China publication-title: Lancet Oncol – reference: Kim L, Garg S, O'Halloran A, Whitaker M, Pham H, Anderson EJ, et al. Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET). Preprint at medRxiv 2020. – volume: 71 start-page: 896 year: 2020 end-page: 897 ident: bb0050 article-title: Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission publication-title: Clin Infect Dis – volume: 132 start-page: 1639 year: 2015 end-page: 1647 ident: bb0315 article-title: Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors publication-title: Circulation – volume: 14 start-page: 655 year: 2020 end-page: 659 ident: bb0135 article-title: Obesity as a predictor for a poor prognosis of COVID-19: a systematic review publication-title: Diabetes Metab Syndr – volume: 369 start-page: m1966 year: 2020 ident: bb0360 article-title: Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study publication-title: BMJ – volume: 21 year: 2020 ident: bb0265 article-title: Risk of COVID-19 for patients with obesity publication-title: Obes Rev – year: 2020 ident: bb0110 article-title: Lung disease severity, coronary artery calcium, coronary inflammation and mortality in coronavirus disease 2019 publication-title: Preprint at medRxiv – start-page: 1 year: 2020 end-page: 8 ident: bb0130 article-title: Visceral adipose tissue in patients with COVID-19: risk stratification for severity [published online ahead of print, 2020 Aug 3] publication-title: Abdom Radiol (NY) – volume: 319 start-page: E105 year: 2020 ident: bb0280 article-title: Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes publication-title: Am J Physiol Endocrinol Metab – volume: 14 start-page: 1149 year: 2020 end-page: 1151 ident: bb0205 article-title: BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: preliminary findings from UK biobank publication-title: Diabetes Metab Syndr – volume: 99 start-page: 47 year: 2020 end-page: 56 ident: bb0255 article-title: Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: a systematic review and meta-analysis [published online ahead of print, 2020 Jul 25] publication-title: Int J Infect Dis – volume: 108 start-page: 154251 year: 2020 ident: bb0250 article-title: Commentary: obesity: the “Achilles heel” for COVID-19? publication-title: Metabolism – reference: . – volume: 16 start-page: 341 year: 2020 end-page: 342 ident: bb0230 article-title: Obesity and impaired metabolic health in patients with COVID-19 publication-title: Nat Rev Endocrinol – volume: 43 start-page: 1392 year: 2020 end-page: 1398 ident: bb0045 article-title: Obesity and COVID-19 severity in a designated Hospital in Shenzhen publication-title: China. Diabetes Care – year: 2020 ident: bb0170 article-title: Association of BMI and obesity with composite poor outcome in COVID-19 adult patients: a systematic review and meta-analysis publication-title: medRxiv – year: 2020 ident: bb0100 article-title: Early experience with COVD-19 patients at tertiary care teaching hospital in southwestern United States publication-title: Preprint at medRxiv – volume: 364 start-page: k4817 year: 2019 ident: bb0080 article-title: When continuous outcomes are measured using different scales: guide for meta-analysis and interpretation publication-title: BMJ – volume: 12 start-page: 653 year: 2011 end-page: 659 ident: bb0220 article-title: Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis publication-title: Obes Rev – year: 2020 ident: bb0380 article-title: Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: an observational retrospective study publication-title: Preprint at medRxiv – volume: 108 start-page: 154249 year: 2020 ident: bb0245 article-title: Letter to the editor: obesity hypoventilation syndrome and severe COVID-19 publication-title: Metabolism – volume: 166 start-page: 108331 year: 2020 ident: bb0395 article-title: Demographic and clinical features of critically ill patients with COVID-19 in Greece: the burden of diabetes and obesity [published online ahead of print, 2020 Jul 17] publication-title: Diabetes Res Clin Pract – volume: 8 year: 2011 ident: bb0225 article-title: Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis publication-title: PLoS Med – volume: 218 start-page: 1378 year: 2018 end-page: 1382 ident: bb0270 article-title: Obesity increases the duration of influenza a virus shedding in adults publication-title: J Infect Dis – volume: 116 start-page: 723 year: 2019 end-page: 731 ident: bb0300 article-title: Nutrition, the visceral immune system, and the evolutionary origins of pathogenic obesity publication-title: Proc Natl Acad Sci U S A – start-page: 154319 year: 2020 ident: bb0070 article-title: Visceral fat shows the strongest association with the need of intensive Care in Patients with COVID-19[published online ahead of print, 2020 Jul 23] publication-title: Metabolism – year: 2020 ident: bb0010 article-title: Coronavirus disease 2019 – volume: 108 start-page: 154256 year: 2020 ident: bb0260 article-title: Letter to the editor: obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease publication-title: Metabolism – year: 2020 ident: bb0025 article-title: Obesity and overweight – year: 2020 ident: bb0375 article-title: Determinants of severity in cancer patients with COVID-19 illness publication-title: Preprint at medRxiv – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0145 article-title: Coronavirus (SARS-CoV-2) and the risk of obesity for critically illness and ICU admitted: meta-analysis of the pidemiological evidence [published online ahead of print, 2020 Aug 3] publication-title: Obes Res Clin Pract – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0115 article-title: Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio Emilia, Italy publication-title: Preprint at medRxiv – volume: 218 start-page: 1378 issue: 9 year: 2018 ident: 10.1016/j.metabol.2020.154378_bb0270 article-title: Obesity increases the duration of influenza a virus shedding in adults publication-title: J Infect Dis doi: 10.1093/infdis/jiy370 – volume: 364 start-page: k4817 year: 2019 ident: 10.1016/j.metabol.2020.154378_bb0080 article-title: When continuous outcomes are measured using different scales: guide for meta-analysis and interpretation publication-title: BMJ doi: 10.1136/bmj.k4817 – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0075 article-title: Visceral Adiposity and High Intramuscular Fat Deposition Independently Predict Critical Illness in Patients with Sars-COV-2 [published online ahead of print, 2020 Jul 17] publication-title: Obesity (Silver Spring) – ident: 10.1016/j.metabol.2020.154378_bb0175 doi: 10.1002/oby.22941 – volume: 154345 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0335 article-title: Obesity & genetic predisposition with COVID-19 publication-title: Metabolism – ident: 10.1016/j.metabol.2020.154378_bb0005 – volume: 44 start-page: 1790 issue: 8 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0290 article-title: COVID-19 and the role of chronic inflammation in patients with obesity publication-title: Int J Obes (Lond) doi: 10.1038/s41366-020-0597-4 – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0015 article-title: Severe Covid-19[published online ahead of print, 2020 May 15] publication-title: N Engl J Med – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0120 article-title: Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico publication-title: Preprint at medRxiv – volume: 31 start-page: 1786 issue: 12 year: 2007 ident: 10.1016/j.metabol.2020.154378_bb0330 article-title: A dose-response relation between aerobic exercise and visceral fat reduction: systematic review of clinical trials publication-title: Int J Obes (Lond) doi: 10.1038/sj.ijo.0803683 – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0035 article-title: Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City publication-title: Preprint at medRxiv – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0095 article-title: Pre-existing traits associated with Covid-19 illness severity publication-title: Preprint at medRxiv – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0350 article-title: Characterization and clinical course of 1000 Patients with COVID-19 in New York: retrospective case series – volume: 166 start-page: 108331 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0395 article-title: Demographic and clinical features of critically ill patients with COVID-19 in Greece: the burden of diabetes and obesity [published online ahead of print, 2020 Jul 17] publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2020.108331 – volume: 39 start-page: e179 issue: 10 year: 2016 ident: 10.1016/j.metabol.2020.154378_bb0305 article-title: Abdominal obesity is more closely associated with diabetic kidney disease than general obesity publication-title: Diabetes Care doi: 10.2337/dc16-1025 – ident: 10.1016/j.metabol.2020.154378_bb0185 – volume: 108 start-page: 154249 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0245 article-title: Letter to the editor: obesity hypoventilation syndrome and severe COVID-19 publication-title: Metabolism doi: 10.1016/j.metabol.2020.154249 – start-page: 154319 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0070 article-title: Visceral fat shows the strongest association with the need of intensive Care in Patients with COVID-19[published online ahead of print, 2020 Jul 23] publication-title: Metabolism doi: 10.1016/j.metabol.2020.154319 – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0200 article-title: Severe obesity as an independent risk factor for COVID-19 mortality in hospitalized patients younger than 50 [published online ahead of print, 2020 May 23] publication-title: Obesity (Silver Spring) – ident: 10.1016/j.metabol.2020.154378_bb0010 – volume: 382 start-page: 2372 issue: 24 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0345 article-title: Clinical characteristics of Covid-19 in New York City publication-title: N Engl J Med doi: 10.1056/NEJMc2010419 – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0365 article-title: Derivation of a score to predict admission to intensive care unit in patients with COVID-19: the ABC-GOALS score publication-title: Preprint at medRxiv – volume: 14 start-page: 655 issue: 4 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0135 article-title: Obesity as a predictor for a poor prognosis of COVID-19: a systematic review publication-title: Diabetes Metab Syndr doi: 10.1016/j.dsx.2020.05.020 – volume: 21 start-page: 335 issue: 3 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0020 article-title: Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China publication-title: Lancet Oncol doi: 10.1016/S1470-2045(20)30096-6 – start-page: 1 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0130 article-title: Visceral adipose tissue in patients with COVID-19: risk stratification for severity [published online ahead of print, 2020 Aug 3] publication-title: Abdom Radiol (NY) – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0030 article-title: Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of general practitioners research and surveillance Centre primary care network: a cross-sectional study[published online ahead of print, 2020 May 15] publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(20)30371-6 – volume: 71 start-page: 896 issue: 15 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0050 article-title: Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission publication-title: Clin Infect Dis doi: 10.1093/cid/ciaa415 – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0150 article-title: Obesity is a risk factor for developing critical condition in COVID-19 patients: a systematic review and meta-analysis [published online ahead of print, 2020 Jul 19] publication-title: Obes Rev – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0110 article-title: Lung disease severity, coronary artery calcium, coronary inflammation and mortality in coronavirus disease 2019 publication-title: Preprint at medRxiv – volume: 14 start-page: 1149 issue: 5 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0205 article-title: BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: preliminary findings from UK biobank publication-title: Diabetes Metab Syndr doi: 10.1016/j.dsx.2020.06.060 – volume: 108 start-page: 154256 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0260 article-title: Letter to the editor: obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease publication-title: Metabolism doi: 10.1016/j.metabol.2020.154256 – ident: 10.1016/j.metabol.2020.154378_bb0090 doi: 10.1093/cid/ciaa1012 – volume: 17 start-page: 43 issue: 1 year: 2012 ident: 10.1016/j.metabol.2020.154378_bb0235 article-title: Impact of obesity on respiratory function publication-title: Respirology doi: 10.1111/j.1440-1843.2011.02096.x – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0100 article-title: Early experience with COVD-19 patients at tertiary care teaching hospital in southwestern United States publication-title: Preprint at medRxiv – ident: 10.1016/j.metabol.2020.154378_bb0180 – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0385 article-title: Sociodemographic predictors of outcomes in COVID-19: examining the impact of ethnic disparities in Northern Nevada – volume: 7 start-page: 715 issue: 9 year: 2019 ident: 10.1016/j.metabol.2020.154378_bb0320 article-title: Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(19)30084-1 – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0170 article-title: Association of BMI and obesity with composite poor outcome in COVID-19 adult patients: a systematic review and meta-analysis publication-title: medRxiv – volume: 108 start-page: 154262 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0060 article-title: Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx publication-title: New York Metabolism – volume: 21 issue: 6 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0265 article-title: Risk of COVID-19 for patients with obesity publication-title: Obes Rev doi: 10.1111/obr.13034 – volume: 132 start-page: 1639 issue: 17 year: 2015 ident: 10.1016/j.metabol.2020.154378_bb0315 article-title: Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.114.015000 – volume: 395 start-page: 1763 issue: 10239 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0065 article-title: Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study publication-title: Lancet doi: 10.1016/S0140-6736(20)31189-2 – volume: 8 issue: 7 year: 2011 ident: 10.1016/j.metabol.2020.154378_bb0225 article-title: Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis publication-title: PLoS Med doi: 10.1371/journal.pmed.1001053 – volume: 369 start-page: m1966 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0360 article-title: Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study publication-title: BMJ doi: 10.1136/bmj.m1966 – volume: 28 start-page: 1200 issue: 7 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0340 article-title: Association of obesity with disease severity among patients with COVID-19 publication-title: Obesity doi: 10.1002/oby.22859 – volume: 163 start-page: 170 issue: 1 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0370 article-title: Factors associated with intubation and prolonged intubation in hospitalized patients with COVID-19 publication-title: Otolaryngol Head Neck Surg doi: 10.1177/0194599820929640 – start-page: 1 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0410 article-title: The impact of obesity on COVID-19 complications: a retrospective cohort study publication-title: Int J Obes (Lond) – volume: 183 start-page: 389 issue: 4 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0400 article-title: How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre publication-title: Eur J Endocrinol doi: 10.1530/EJE-20-0541 – volume: S0163-4453 start-page: 30288 issue: 20 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0240 article-title: Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19 [published online ahead of print, 2020 May 15] publication-title: J Infect – volume: 12 start-page: 653 issue: 8 year: 2011 ident: 10.1016/j.metabol.2020.154378_bb0220 article-title: Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis publication-title: Obes Rev doi: 10.1111/j.1467-789X.2011.00864.x – volume: 99 start-page: 47 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0255 article-title: Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: a systematic review and meta-analysis [published online ahead of print, 2020 Jul 25] publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2020.07.029 – volume: 57 start-page: 759 issue: 6 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0215 article-title: Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic publication-title: Acta Diabetol doi: 10.1007/s00592-020-01522-8 – volume: 158 start-page: 104931 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0055 article-title: 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study publication-title: Pharmacol Res doi: 10.1016/j.phrs.2020.104931 – volume: 319 start-page: E105 issue: 1 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0280 article-title: Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00198.2020 – volume: 28 start-page: 1195 issue: 7 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0040 article-title: High prevalence of obesity in severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation publication-title: Obesity (Silver Spring) doi: 10.1002/oby.22831 – start-page: 1 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0140 article-title: Higher body mass index is an important risk factor in COVID-19 patients: a systematic review and meta-analysis [published online ahead of print, 2020 Jul 24] publication-title: Environ Sci Pollut Res Int – volume: 115 start-page: 1081 issue: 5 year: 2018 ident: 10.1016/j.metabol.2020.154378_bb0275 article-title: Bueno de Mesquita PJ, Albert B, Liu F, et al. Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1716561115 – volume: 395 start-page: 1544 issue: 10236 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0195 article-title: Obesity could shift severe COVID-19 disease to younger ages publication-title: The Lancet doi: 10.1016/S0140-6736(20)31024-2 – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0380 article-title: Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: an observational retrospective study – ident: 10.1016/j.metabol.2020.154378_bb0160 doi: 10.1016/j.orcp.2020.07.002 – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0165 article-title: Obesity aggravates COVID-19: a systematic review and meta-analysis [published online ahead of print, 2020 Jun 30] publication-title: J Med Virol – volume: 16 start-page: 341 issue: 7 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0230 article-title: Obesity and impaired metabolic health in patients with COVID-19 publication-title: Nat Rev Endocrinol doi: 10.1038/s41574-020-0364-6 – volume: 43 start-page: 1392 issue: 7 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0045 article-title: Obesity and COVID-19 severity in a designated Hospital in Shenzhen publication-title: China. Diabetes Care doi: 10.2337/dc20-0576 – ident: 10.1016/j.metabol.2020.154378_bb0025 – volume: 8 start-page: 343 year: 2018 ident: 10.1016/j.metabol.2020.154378_bb0210 article-title: Back to the future: lessons learned from the 1918 influenza pandemic publication-title: Front Cell Infect Microbiol doi: 10.3389/fcimb.2018.00343 – start-page: e3325 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0295 article-title: Obesity and SARS-CoV-2: a population to safeguard publication-title: Diabetes Metab Res Rev doi: 10.1002/dmrr.3325 – ident: 10.1016/j.metabol.2020.154378_bb0125 doi: 10.2337/dc20-1333 – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0355 article-title: COVID-19: impact of obesity and diabetes in disease severity publication-title: Preprint at medRxiv – volume: 223 start-page: 14 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0105 article-title: Clinical characteristics and outcomes of hospitalized and critically ill children and adolescents with coronavirus disease 2019 (COVID-19) at a tertiary care medical center in New York City publication-title: J Pediatr doi: 10.1016/j.jpeds.2020.05.006 – volume: S1262-3636 start-page: 30097 issue: 20 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0155 article-title: Body mass index and outcome in patients with COVID-19: a dose-response meta-analysis [published online ahead of print, 2020 Jul 29] publication-title: Diabetes Metab – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0375 article-title: Determinants of severity in cancer patients with COVID-19 illness – volume: 383 start-page: 187 issue: 2 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0190 article-title: Coronavirus infection in pediatric emergency departments research G. children with Covid-19 in pediatric emergency departments in Italy publication-title: N Engl J Med doi: 10.1056/NEJMc2007617 – volume: 116 start-page: 723 issue: 3 year: 2019 ident: 10.1016/j.metabol.2020.154378_bb0300 article-title: Nutrition, the visceral immune system, and the evolutionary origins of pathogenic obesity publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1809046116 – volume: 50 start-page: 425 issue: 4 year: 2001 ident: 10.1016/j.metabol.2020.154378_bb0310 article-title: deJonge L, de la Bretonne J, et al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity publication-title: Metabolism doi: 10.1053/meta.2001.21693 – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0085 article-title: A cohort of patients with COVID-19 in a major teaching hospital in Europe publication-title: Preprint at medRxiv – volume: 108 start-page: 154251 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0250 article-title: Commentary: obesity: the “Achilles heel” for COVID-19? publication-title: Metabolism doi: 10.1016/j.metabol.2020.154251 – volume: 110 start-page: 154317 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0325 article-title: The role of visceral adiposity in the severity of COVID-19: highlights from a unicenter cross-sectional pilot study in Germany publication-title: Metabolism doi: 10.1016/j.metabol.2020.154317 – year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0390 article-title: Survival in adult inpatients with COVID-19 publication-title: Preprint at medRxiv – volume: 142 start-page: 4 issue: 1 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0285 article-title: Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.120.047659 – volume: 21 start-page: 752 issue: 4 year: 2020 ident: 10.1016/j.metabol.2020.154378_bb0405 article-title: In young adults with COVID-19, obesity is associated with adverse outcomeS publication-title: West J Emerg Med doi: 10.5811/westjem.2020.5.47972 |
| SSID | ssj0007786 |
| Score | 2.6940377 |
| SecondaryResourceType | review_article |
| Snippet | Obesity is common in patients with coronavirus disease 2019 (COVID-19). The effects of obesity on clinical outcomes of COVID-19 warrant systematical... • Obesity increases risk for hospitalization among patients with COVID-19. • Obesity increases risk for needing ICU admission among patients with COVID-19. •... |
| SourceID | pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 154378 |
| SubjectTerms | Body Mass Index Coronavirus disease 2019 COVID-19 - complications COVID-19 - epidemiology COVID-19 - mortality COVID-19 - therapy COVID-19 in Metabolism Hospitalization - statistics & numerical data Humans Intensive care Intensive Care Units - statistics & numerical data Intra-Abdominal Fat - diagnostic imaging Intra-Abdominal Fat - pathology Intra-Abdominal Fat - physiology Invasive mechanical ventilation Mortality Obesity Obesity - complications Obesity - diagnosis Obesity - epidemiology Obesity - therapy Pandemics Patient Admission - statistics & numerical data Prognosis Respiration, Artificial - statistics & numerical data Risk Factors SARS-CoV-2 - physiology Severity of Illness Index Tomography, X-Ray Computed Visceral adipose tissue |
| Title | Obesity in patients with COVID-19: a systematic review and meta-analysis |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0026049520302420 https://dx.doi.org/10.1016/j.metabol.2020.154378 https://www.ncbi.nlm.nih.gov/pubmed/33002478 https://www.proquest.com/docview/2448408331 https://pubmed.ncbi.nlm.nih.gov/PMC7521361 |
| Volume | 113 |
| WOSCitedRecordID | wos000593872400007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1532-8600 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007786 issn: 0026-0495 databaseCode: AIEXJ dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfYBoiXCQaDsjEZiTeUkg8ndnibtqEN0YHEGOUp8kciOm3utLZo_PecY8dpWtAGEi9R4-SSxvezc-fc_Q6hV0oQQjMYaVyEJCA8DAOWEtjNlKxizlRZl_M5_UCPj9lwmH9yVVEndTkBqjW7vs4v_6uqoQ2UbVJn_0Ld_qLQAL9B6bAFtcP2Vop3VP-vW9JUl8G29_H0aD-IcpvfvEjhbCODL8opD7gjKpk3XAdwQIzPTZwGKMXnUxqZ-SIBLUrcOvS3kQ_5mdX7fLx8DtfBoPQnfnXNA0cK7tYk4sX4Dp8s04nlNO5eAA5J2pl8bSbq0kRu1xTO-hf26frmLmYVLLEFfxY4sj_X1Ghw6RjmLDA6whW0FtM0h2lubffoYPjev5wNXZ6N-rH_pU3qevPbm_3JXFl2RxajaufMlJOHaN35F3jX4uIRulPqDXTPVhz9uYHuD1wsxWN06ICCRxo3QMEGKLgBylvMcQsTbGGCQeW4A5Mn6Mu7g5O9w8DV1QikKV8RUAFmWco4FRUY_5QTUUmVgqWiVJyqSlIqmEgFuJ452DeGwLDMKkmikvAsFFIlm2hVj3X5DGGuiJQZ-KyVyohUBNyPKsvNt-GIJ4yzHiJN9xXSkc6b2ifnRRNdeFa4Xi9Mrxe213uo78UuLevKTQJZo5uiGQLwEiwATjcJMi_obE5rS95G9GUDggLmZPOhjetyPJsUYDIzAr5NEvXQUwsK_xhJYsxiI007cPEnGL737hE9-l7zvlPQXpJFz__1WbfQg3awbqPV6dWsfIHuyh_T0eRqB63QIdtx4-UXgrjOsQ |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Obesity+in+patients+with+COVID-19%3A+a+systematic+review+and+meta-analysis&rft.jtitle=Metabolism%2C+clinical+and+experimental&rft.au=Huang%2C+Yi&rft.au=Lu%2C+Yao&rft.au=Huang%2C+Yan-Mei&rft.au=Wang%2C+Min&rft.date=2020-12-01&rft.pub=Elsevier+Inc&rft.issn=0026-0495&rft.volume=113&rft_id=info:doi/10.1016%2Fj.metabol.2020.154378&rft.externalDocID=S0026049520302420 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0026-0495&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0026-0495&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0026-0495&client=summon |